← Open Payments lookup

KEVIN HALE: Open Payments

NPI 1922101716 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$786 in 47 payments from 14 companies in 2025. Trend: 2023 $1,086 · 2024 $943 · 2025 $786

Food & beverage: $786
CompanyPaymentsAmount
ABBVIE INC.18$257
AstraZeneca Pharmaceuticals LP6$112
PFIZER INC.5$92
Amgen Inc.5$74
Otsuka America Pharmaceutical, Inc.3$71
Abbott Laboratories2$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$22
Actelion Pharmaceuticals US, Inc.1$21
VERTEX PHARMACEUTICALS INCORPORATED1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17

Products named: VRAYLAR, QULIPTA, FARXIGA, REXULTI, OTEZLA, NURTEC ODT, UBRELVY, PREVNAR 20.

Industry payments across AR — which companies pay providers there.